Healthpeak Properties (DOC)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-07-07
$21.95+0.90%
Close 2026-07-07 · 1-day change
Reading DOC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DOC free→NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-07-07
Reading DOC? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track DOC free→A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
DOC is positioned as a stable investment within the Real Estate sector, with a medium confidence level. The current thesis reflects a mix of strong recent financial performance and moderate risks due to sector challenges.
The market currently prices DOC at a premium compared to its peers, indicating that expectations are somewhat high. The valuation is considered expensive, with a low expectations gap suggesting that the market is not overly fragile at this time.
Management has reaffirmed guidance for 2026 FFO, which is a positive sign. However, there are mixed signals regarding NOI and EPS guidance, and the near-term risk of missing estimates is moderate, reflecting the industry's high miss rate.
The long-term thesis hinges on key factors such as the potential for the Federal Reserve to cut interest rates, which could benefit DOC. Additionally, the performance of sector leaders like WELL, VTR, and OHI will be crucial in determining the overall momentum in the Real Estate sector.
Over the next 1 to 3 years, DOC's performance will depend on external economic factors and sector dynamics. Not investment advice.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. This improvement is driven by the latest earnings beat and the reaffirmation of the 2026 FFO guidance, which supports growth expectations. There are no significant threats noted that could weaken this positive outlook.
as of 2026-07-07
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Reaffirming FFO guidance shows good financial health and steady operations. It comforts investors.
Confirms:Management confirms FFO guidance for 2026 remains on track during the next earnings call.
Disproves:Management revises FFO guidance downward in the next earnings call.
Why it matters: Earnings results will show how well Healthpeak is performing against its updated guidance.
Confirms one read:Earnings per share exceeds the updated guidance range of $0.46 to $0.50.
Confirms the other:Earnings per share falls below the updated guidance range of $0.46 to $0.50.
Why it matters: Guidance on Same-Store Cash NOI growth shows how well Healthpeak is managing its properties. It impacts investor confidence.
Confirms one read:Management says Same-Store Cash NOI growth is over 1.0%.
Confirms the other:Management says Same-Store Cash NOI growth is below -1.0%.
Why it matters: News on Janus Living's acquisitions can show Healthpeak's growth and affect earnings.
Confirms:Janus Living buys $400 million in senior housing.
Disproves:Janus Living cancels or delays some planned purchases.
Why it matters: A rebound in sector revenue growth could boost Healthpeak's performance and outlook.
Confirms:Sector revenue growth shows signs of speeding up toward past highs.
Disproves:Sector revenue growth keeps slowing down.
Why it matters: Updates on share buybacks show management's trust in the company.
Confirms:Healthpeak announces more share buybacks over the $306 million limit.
Disproves:Healthpeak stops or cuts share repurchase activity.
Why it matters: Changes in EPS guidance can show shifts in profit expectations. This impacts value.
Confirms one read:Management raises 2026 EPS guidance in the next earnings call.
Confirms the other:Management lowers 2026 EPS guidance in the next earnings call.
Why it matters: This guidance shows confidence in steady revenue. It builds trust with investors.
Confirms:Management will confirm 2026 NOI growth guidance at the next earnings call.
Disproves:Management lowers the 2026 NOI growth guidance in the next earnings call.